Mahyar Janahmadi Selected Research

Naloxone (Narcan)

1/2022	Involvement of Hippocampal Astrocytic Connexin-43 in Morphine dependence.
1/2021	The role of hippocampal glial glutamate transporter (GLT-1) in morphine-induced behavioral responses.
1/2018	Hippocampal glial cells modulate morphine-induced behavioral responses.
1/2017	Antagonism of orexin type-1 receptors (OX1Rs) attenuates naloxone-precipitated morphine withdrawal syndrome in rat dorsal hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahyar Janahmadi Research Topics

Disease

6	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2012
5	Morphine Dependence 10/2023 - 01/2017
5	Ataxia (Dyssynergia) 09/2022 - 05/2009
4	Seizures (Absence Seizure) 03/2024 - 01/2017
4	Cerebellar Ataxia (Dysmetria) 09/2022 - 05/2009
4	Pain (Aches) 01/2021 - 01/2009
3	Autistic Disorder (Autism) 10/2023 - 01/2021
3	Epilepsy (Aura) 01/2023 - 07/2013
3	Diarrhea 01/2022 - 01/2017
2	Cognitive Dysfunction 03/2024 - 01/2019
2	Temporal Lobe Epilepsy 01/2023 - 01/2023
2	Tremor (Tremors) 01/2022 - 01/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 09/2017
2	Memory Disorders (Memory Loss) 01/2018 - 09/2017
2	Hyperalgesia 01/2009 - 07/2006
1	Cerebellar Diseases (Cerebellar Syndrome) 01/2023
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Hearing Loss (Hearing Impairment) 05/2020
1	Ototoxicity 05/2020
1	Myalgia 01/2020
1	Obesity 01/2019
1	Autism Spectrum Disorder 01/2019
1	Insulin Resistance 01/2018
1	Inflammation (Inflammations) 01/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2015
1	Periodontitis 01/2014
1	Nervous System Diseases (Neurological Disorders) 07/2013
1	Dementia (Dementias) 01/2012
1	Type 2 Episodic Ataxia 09/2010
1	Neuralgia (Stump Neuralgia) 07/2006

Drug/Important Bio-Agent (IBA)

5	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 07/2006
4	Amyloid beta-PeptidesIBA 01/2023 - 01/2012
4	Naloxone (Narcan)FDA LinkGeneric 01/2022 - 01/2017
3	Valproic Acid (Depakote)FDA LinkGeneric 10/2023 - 01/2019
3	Formaldehyde (Formol)FDA Link 01/2021 - 01/2009
3	Neuroprotective AgentsIBA 01/2019 - 05/2009
3	Riluzole FDA LinkGeneric 01/2017 - 05/2009
3	3-acetylpyridineIBA 01/2013 - 05/2009
2	Pentylenetetrazole (Metrazol)IBA 03/2024 - 12/2020
2	NADPH Dehydrogenase (Dehydrogenase, NADP)IBA 01/2023 - 10/2022
2	Kainic Acid (Kainate)IBA 01/2023 - 01/2023
2	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020 - 01/2017
2	Potassium Channels (Potassium Channel)IBA 01/2015 - 01/2013
1	Connexin 43 (Connexin43)IBA 10/2023
1	Cannabinoid Receptor AntagonistsIBA 01/2023
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2022
1	CannabinoidsIBA 09/2022
1	pyridineIBA 09/2022
1	Therapeutic UsesIBA 09/2022
1	Cannabinoid Receptor AgonistsIBA 09/2022
1	TAT-Gap19 peptideIBA 01/2022
1	CationsIBA 01/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2021
1	Serotonin ReceptorsIBA 01/2021
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 05/2020
1	Acid Sensing Ion ChannelsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2017
1	sodium bisulfide (NaHS)IBA 09/2017
1	SodiumIBA 01/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2017
1	OrexinsIBA 01/2017
1	1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA 01/2017
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2015
1	Ion Channels (Ion Channel)IBA 01/2015
1	anethole (trans-anethole)IBA 01/2014
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2013
1	PotassiumIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)IBA 12/2010
1	AMPA Receptors (AMPA Receptor)IBA 12/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2010
1	Analgesics (Analgesic Drugs)IBA 12/2010
1	4-Aminopyridine (4 Aminopyridine)FDA Link 09/2010
1	Pemetrexed (MTA)FDA Link 01/2009
1	EugenolIBA 01/2009
1	Ketoprofen (Orudis)FDA LinkGeneric 01/2009
1	Dizocilpine Maleate (Dizocilpine)IBA 07/2006

Therapy/Procedure

6	Therapeutics 01/2023 - 07/2013
1	Drug Therapy (Chemotherapy) 01/2021
1	Subcutaneous Injections 01/2021
1	Persian Medicine 12/2020
1	Deep Brain Stimulation 07/2013